FDA.reportPublic FDA data

Azopt 10 MG/ML Ophthalmic Suspension

RxCUI
213272
RxNorm name
Azopt 10 MG/ML Ophthalmic Suspension
Display name
Azopt 10 MG/ML Ophthalmic Suspension
Full name
Azopt 10 MG/ML Ophthalmic Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AzoptBRINZOLAMIDESandoz Inc0afb6589-51ba-432c-aed1-20a12d5d34552023-11-24Warnings, Adverse reactionsExact identifier
rxcui: 213272

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
0afb6589-51ba-432c-aed1-20a12d5d3455Azopt 10 MG/ML Ophthalmic SuspensionSY1These highlights do not include all the information needed to use AZOPT safely and effectively. See full prescribing information for AZOPT. AZOPT ® (brinzolamide ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 199820231124
0afb6589-51ba-432c-aed1-20a12d5d3455Azopt 1 % Ophthalmic SuspensionSY1These highlights do not include all the information needed to use AZOPT safely and effectively. See full prescribing information for AZOPT. AZOPT ® (brinzolamide ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 199820231124
0afb6589-51ba-432c-aed1-20a12d5d3455Azopt 1 % Ophthalmic SuspensionPSN1These highlights do not include all the information needed to use AZOPT safely and effectively. See full prescribing information for AZOPT. AZOPT ® (brinzolamide ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 199820231124
0afb6589-51ba-432c-aed1-20a12d5d3455brinzolamide 10 MG/ML Ophthalmic Suspension [Azopt]SBD1These highlights do not include all the information needed to use AZOPT safely and effectively. See full prescribing information for AZOPT. AZOPT ® (brinzolamide ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 199820231124